CIK 0001653087 · Accelerated filer<br>Smaller reporting company
Alector, Inc.
Sign in to watch- Ticker
- ALEC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 822933343
- Phone
- 415-231-5660
- Business address
- 131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Alector LLC
- 4 Open-market sale Principal Accounting Officer sold 4,753 shares at $1.21 ($5,751)
- 144 Insider Sale of Securities
- 4 Open-market sale Principal Accounting Officer sold 8,056 shares at $1.12 ($9,019)
- 4 Open-market sale Chief Executive Officer sold 104,347 shares at $1.12 ($116,827)
- 4 Open-market sale President and Head of R&D sold 41,687 shares at $1.12 ($46,673)
- 4 Open-market sale Chief Bus Ofcr & Interim CFO sold 37,261 shares at $1.12 ($41,717)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Grant or award Principal Accounting Officer acquired 32,343 shares (grant or award)
- 4 Grant or award Chief Bus Ofcr & Interim CFO acquired 65,000 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 174,167 shares (grant or award)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Results of operations · Exit or restructuring costs · Executive or director change · Regulation FD disclosure
Page 5 of 32 · 631 filings